Gene · 375790
Papers3,257
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,257
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A comprehensive map of proteoglycan expression and deposition in the pulmonary arterial wall in health and pulmonary hypertension. | Am J Physiol Lung Cell Mol Physiol | 2024 | 38771138 | PubTator, text mining | PubMed |
| The MuSK agonist antibody protects the neuromuscular junction and extends the lifespan in C9orf72-ALS mice. | Mol Ther | 2024 | 38734896 | PubTator, text mining | PubMed |
| Building, Breaking, and Repairing Neuromuscular Synapses. | Cold Spring Harb Perspect Biol | 2024 | 38697654 | PubTator, text mining | PubMed |
| Congenital myasthenic syndromes in adults: clinical features, diagnosis and long-term prognosis. | Brain | 2024 | 38696726 | PubTator, text mining | PubMed |
| The Significance of Selected Myokines in Predicting the Length of Rehabilitation of Patients after COVID-19 Infection. | Biomedicines | 2024 | 38672190 | PubTator, text mining | PubMed |
| Plasma Proteins Associated with Chronic Histopathologic Lesions on Kidney Biopsy. | J Am Soc Nephrol | 2024 | 38656806 | PubTator, text mining | PubMed |
| The impact of canonical Wnt transcriptional repressors TLE3 and TLE4 on postsynaptic transcription at the neuromuscular junction. | Front Mol Neurosci | 2024 | 38600964 | PubTator, text mining | PubMed |
| Suppression of AGRN enhances CD8+ T cell recruitment and inhibits breast cancer progression. | FASEB J | 2024 | 38568853 | PubTator, text mining | PubMed |
| Lipid-Lowering Medications are Associated with Reduced Sarcopenia-Related Quality of Life in Older Adults with Hyperlipidemia. | Drugs Aging | 2024 | 38564165 | PubTator, text mining | PubMed |
| Prevention of age-related neuromuscular junction degeneration in sarcopenia by low-magnitude high-frequency vibration. | Aging Cell | 2024 | 38532712 | PubTator, text mining | PubMed |
| Motor neurons and endothelial cells additively promote development and fusion of human iPSC-derived skeletal myocytes. | Skelet Muscle | 2024 | 38454511 | PubTator, text mining | PubMed |
| The effects of TRX suspension training on sarcopenic biomarkers and functional abilities in elderlies with sarcopenia: a controlled clinical trial. | BMC Sports Sci Med Rehabil | 2024 | 38409184 | PubTator, text mining | PubMed |
| Observing Dynamic Conformational Changes within the Coiled-Coil Domain of Different Laminin Isoforms Using High-Speed Atomic Force Microscopy. | Int J Mol Sci | 2024 | 38396630 | PubTator, text mining | PubMed |
| The α-dystroglycan N-terminus is a broad-spectrum antiviral agent against SARS-CoV-2 and enveloped viruses. | Antiviral Res | 2024 | 38387750 | PubTator, text mining | PubMed |
| Agrin Inhibition in Enteric Neural Stem Cells Enhances Their Migration Following Colonic Transplantation. | Stem Cells Transl Med | 2024 | 38387006 | PubTator, text mining | PubMed |
| Assessing the impact of novel risk loci on Alzheimer's and Parkinson's diseases in a Chinese Han cohort. | Front Neurol | 2024 | 38356889 | PubTator, text mining | PubMed |
| Monogenic Causes Identified in 23.68% of Children with Steroid-Resistant Nephrotic Syndrome: A Single-Centre Study. | Kidney Dis (Basel) | 2024 | 38322629 | PubTator, text mining | PubMed |
| Uncovering Novel Extracellular Matrix Transcriptome Alterations in Lesions of Multiple Sclerosis. | Int J Mol Sci | 2024 | 38279239 | PubTator, text mining | PubMed |
| Registered trials on novel therapies for myasthenia gravis: a cross-sectional study on ClinicalTrials.gov. | Sci Rep | 2024 | 38267496 | PubTator, text mining | PubMed |
| Plectin plays a role in the migration and volume regulation of astrocytes: a potential biomarker of glioblastoma. | J Biomed Sci | 2024 | 38263015 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/375790/papers?page=9